Abstract
MicroRNA (abbr. miRNA) is an endogenous small non-coding RNAs (containing ~22 nucleotides) found in plants and animals, which functions in transcriptional and post-transcriptional regulation of gene expression. These endogenous gene expression inhibitors were primarily described in cancer but recent emerging roles in the regulation of autoimmune inflammation which is thought to be associated with cardiovascular diseases (CVDs), including atherosclerosis known as an autoimmune disease. MiRNA controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ, and plays the roles in endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophages, and thereby leading to regulate the progression of atherosclerosis. MiRNA modulates several pathways such as lipid uptake and Toll-like receptor (TLR) signaling, implicating an involvement in plaque development. In the present review, we focus on the roles of microRNAs in atherosclerosis through which highlight the therapeutic possibility for the treatment of atherosclerosis.
Keywords: Atherosclerosis, autoantibodies, MicroRNA, Toll-like receptor and inflammatory.
Current Medicinal Chemistry
Title:The Roles of MicroRNAs in Atherosclerosis
Volume: 21 Issue: 13
Author(s): Xinjie Lu and Vijay Kakkar
Affiliation:
Keywords: Atherosclerosis, autoantibodies, MicroRNA, Toll-like receptor and inflammatory.
Abstract: MicroRNA (abbr. miRNA) is an endogenous small non-coding RNAs (containing ~22 nucleotides) found in plants and animals, which functions in transcriptional and post-transcriptional regulation of gene expression. These endogenous gene expression inhibitors were primarily described in cancer but recent emerging roles in the regulation of autoimmune inflammation which is thought to be associated with cardiovascular diseases (CVDs), including atherosclerosis known as an autoimmune disease. MiRNA controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ, and plays the roles in endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophages, and thereby leading to regulate the progression of atherosclerosis. MiRNA modulates several pathways such as lipid uptake and Toll-like receptor (TLR) signaling, implicating an involvement in plaque development. In the present review, we focus on the roles of microRNAs in atherosclerosis through which highlight the therapeutic possibility for the treatment of atherosclerosis.
Export Options
About this article
Cite this article as:
Lu Xinjie and Kakkar Vijay, The Roles of MicroRNAs in Atherosclerosis, Current Medicinal Chemistry 2014; 21 (13) . https://dx.doi.org/10.2174/0929867321666131218100606
DOI https://dx.doi.org/10.2174/0929867321666131218100606 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic:Metabolic Therapy: An Important Therapeutic Option for the Treatment of Cardiovascular Diseases (Executive Editors: G.M.C. Rosano and G. Barbaro)]
Current Pharmaceutical Design Use of Bromine-76 and Iodine-123 Radiohalogenated Tracers in the Drug Development Process
Current Pharmaceutical Design The STAT3 Inhibitor Stattic Impairs Cardiomyocyte Mitochondrial Function Through Increased Reactive Oxygen Species Formation
Current Pharmaceutical Design Gender Related Issues in the Management of Heart Failure
Current Pharmaceutical Design Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1
Current Drug Metabolism Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets
Current Drug Targets Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Current Diabetes Reviews Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Meet the Editorial Board:
Current Drug Targets Gene Therapy Approaches to Ataxias
Current Gene Therapy Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design The Critical Role of Toll-Like Receptor Signaling Pathways in the Induction and Progression of Autoimmune Diseases
Current Molecular Medicine Analytical Methods for the Quantification of Selenium Species in Biological Matrix: Where are We?
Current Nutraceuticals Advancement of Mechanisms of Coxsackie Virus B3-Induced Myocarditis Pathogenesis and the Potential Therapeutic Targets
Current Drug Targets Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Current Vascular Pharmacology The Role of Adipokines in Hypertension and Cardiovascular Disease
Current Hypertension Reviews